ArticleBMC rheumatology2020

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.

Proton Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.